63 customized services results for

ProBio and DAAN have agreed to strengthen their cooperation in the cell and gene therapy(CGT) and biologics

and VEGFR would activate luciferase reporter gene expression.

efficiency and longer protein expression time, and also avoids the genetic risk of introducing foreign genes

It is a milestone on the path to industrialization of the cell and gene therapy industry, pioneered by

We will be able to meet the rapidly evolving demands of gene, cell, antibody and protein therapies.

AAV vector is the most widely used vehicle in delivering gene of interest (GOI) in in vivo gene therapies.ProBio

The demand for viral vectors is rapidly increasing due to the recent growth of the gene therapy market

trials, and has successfully delivered a number of CMC and GMP production projects.ProBio 's integrated gene

synthesis to Top 6 clones14 weeks from gene synthesis to Top 1 clone Excellent DeliverablesAntibody

expedited timeline, good Ab sequence diversity and better cost-effectiveness.Case Study: TIGIT RGA Reporter Gene